Surgical Manual from Roswell Park Created to Advance Bladder Cancer Surgery Worldwide - Top-Institutions - MDSpire

Surgical Manual from Roswell Park Created to Advance Bladder Cancer Surgery Worldwide

Roswell Park Comprehensive Cancer Center announces the release of a new operative surgical manual authored by Khurshid Guru, MD.

  • By

  • July 8, 2026

  • 5 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, NY

    Key Differentiators

    • Urology

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Urology

  • #3

    Henry Ford Health System
    Henry Ford Health System

    Detroit, MI

    Key Differentiators

    • Urology

  • #4

    University of California
    University of California

    Los Angeles, CA

    Key Differentiators

    • Urology

  • #5

    Memorial Sloan Kettering
    Memorial Sloan Kettering

    New York, NY

    Key Differentiators

    • Urology

Original Source(s)

Surgical Manual from Roswell Park Created to Advance Bladder Cancer Surgery Worldwide

  • by

  • July 8, 2026

Related Content

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

  • by

  • July 7, 2026

  • 8 min
ASCO26: Michael Hassett, MD, MPH, eSyM

Dr. Michael Hassett of Dana-Farber Cancer Institute shared new findings showing deployment of eSyM, an ePRO-based, EHR-integrated symptom management program, was associated with statistically significant and potentially meaningful improvements in overall survival. Strategies to improve adoption of ePRO-based symptom management may be warranted.

  • July 1, 2026

  • 1 min
ASCO26: Alicia Morgans, MD, MPH, ARACOG

Dr. Alicia Morgans of Dana-Farber Cancer Institute reported at #ASCO26 that ARACOG found darolutamide was associated with less decline in cognitive testing than enzalutamide, which may help guide treatment choice.

  • July 1, 2026

  • 1 min